Clinical Trials Logo

Sequelae of; Infection clinical trials

View clinical trials related to Sequelae of; Infection.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04809974 Completed - Covid19 Clinical Trials

Clinical Trial of Niagen to Examine Recovery in People With Persistent Cognitive and Physical Symptoms After COVID-19 Illness (Long-COVID)

Start date: July 22, 2021
Phase: Phase 4
Study type: Interventional

The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry ("Long-COVID" "Long-haulers"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments.